CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 29)
13 Feb 2023 The Chinese medical device m...
CROSBY Research – Nagacorp (3918 HK): Recovering from the pandemic
10 Feb 2023 Naga’s FY22 revenue was up b...
CROSBY Research – Vinda International (3331 HK): The worst should be over
31 Jan 2023 Vinda announced FY22 results...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 28)
30 Jan 2023 A total of 484,505 tourists...
CROSBY Research – Xtep International (1368 HK/BUY): The worst has passed, a year of recovery in 2023
19 Jan 2023 Xtep reported its 4Q22 opera...
CROSBY Research – China Everbright Greentech (1257 HK/BUY): FY22 results preview
13 Jan 2023 CEG’s 1H22 revenue edged dow...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 27)
09 Jan 2023 HK/China border fully reopen...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 26) – Feature Article: Renewable Energy – Demand for distributed wind power on the rise
05 Dec 2022 Decentralized wind power is...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 25)
22 Nov 2022 Hong Kong unemployment rate...
CROSBY Research – Man Wah (1999 HK): Higher GPM on lower RM costs
16 Nov 2022 Man Wah reported its Sept en...
CROSBY Research – Microport NeuroTech (2172 HK): A premium Chinese neuro-interventional medical device play
15 Nov 2022 Newly debuted on HKEX in Jul...
CROSBY Research – Channel Micron (2115 HK): Key beneficiary of China’s massive semiconductor factory buildout
09 Nov 2022 Channel Micron is a leading...
CROSBY Research – Precision Tsugami (China) (1651 HK/BUY): Tough 1H23 amid pandemic headwinds
09 Nov 2022 Following a spectacular FY22...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 24)
07 Nov 2022 Increasing investment in Chi...
CROSBY Research – TMT sector: Cleanroom facility segment, a hidden gem benefited from China’s massive semiconductor factory buildout
07 Nov 2022 China government strongly su...
CROSBY Research – China Suntien Green Energy (956 HK/BUY): 3Q22 revenue up 22.8% YoY
07 Nov 2022 Suntien reported its 3Q22 P/...
CROSBY Research – MicroPort CardioFlow (2160 HK): Innovative structural heart disease implantation specialist
07 Nov 2022 Listed in 2021, MicroPort Ca...
CROSBY Research – Xtep (1368 HK/BUY): Retail growth slowdown in Sept
01 Nov 2022 Xtep reported its 3Q22 opera...